The Federal State Unitary Enterprise “Moscow Endocrine Plant” is broadening its international collaboration by enhancing its partnership with the Serbian Ministry of Health. In early December, a meeting took place where Endopharm CEO Mikhail Fonarev engaged with representatives from the Serbian healthcare system to explore opportunities for collaboration.
Discussions emphasized the urgent need to secure medical supplies for Serbian healthcare. Meeting participants addressed key issues such as drug registration processes, optimization of supply chains, and the potential for technology transfer.
Mirsad Djerlek, State Secretary in Serbia’s Ministry of Health, is ready to enhance partnerships and highlighted the need for dialogue in the pharmaceutical sector. The Serbian delegation toured Endopharm’s production facilities, where they commended the advanced technological processes and the robust quality control system in place.
Endopharm received the Serbian GMP certificate this year. Currently, the company exports its products to 18 countries, encompassing the EAEU, the Middle East, and the CIS.
